Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Volume of transactions in the OTC equity market with CCs exceeded ₽10 billion

8/3/23 MOEX

Warner Bros. Discovery reported for 6 months 2023

8/3/23 WBD

Rostelecom reported for 6 months of 2023 by RAS

8/3/23 RTKM

Moderna reported for 6 months of 2023

8/3/23 MRNA

Regeneron reported for 6 months of 2023

8/3/23 REGN

INARCTICA reported for 6 months of 2023 by RAS

8/3/23 AQUA

Moscow Exchange became first CFA exchange operator

8/3/23 MOEX

Beluga Group decided to change its name to NovaBev Group

8/3/23 BELU

VEON's revenues in the 1st half of the year decreased by 6.5%

8/3/23 VEON

Rostelecom reported for 6 months of 2023 by IFRS

8/3/23 RTKM